• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2018-2020 年意大利老年人群出院后产碳青霉烯酶肠杆菌科肠道定植的动态。

Dynamics of carbapenemase-producing Enterobacterales intestinal colonisation in the elderly population after hospital discharge, Italy, 2018-2020.

机构信息

Italian Society of Infectious and Tropical Diseases (SIMIT), Prato, Italy; IRCCS Istituto Auxologico Italiano, San Luca Hospital, Milan, Italy.

IRCCS Fondazione Santa Lucia, Rome, Italy.

出版信息

Int J Antimicrob Agents. 2022 Jun;59(6):106594. doi: 10.1016/j.ijantimicag.2022.106594. Epub 2022 Apr 25.

DOI:10.1016/j.ijantimicag.2022.106594
PMID:35483624
Abstract

Carbapenemase-producing Enterobacterales (CPE) represent a serious threat to public health worldwide. Elderly patients are at increased risk of colonisation/infection with CPE. This study aimed to evaluate the persistence of CPE colonisation and the genotypic characteristics of persistent strains in elderly people discharged from Italian hospitals. A longitudinal study was conducted in two Italian cities (March 2018 to September 2020) enrolling 137 patients aged ≥65 years with CPE intestinal colonisation at hospital discharge. CPE colonisation was evaluated after 4, 8 and 12 months. Competing risk analysis was used to explore the association between baseline characteristics and persistence at 4 months. For all isolates, carbapenemase typing and multilocus sequence typing were performed. Persistent isolates underwent whole-genome sequencing. Of 137 patients, 91% carried carbapenemase-producing Klebsiella pneumoniae (CP-KP) and 8.8% carried carbapenemase-producing Escherichia coli. Although a large number of patients were lost to follow-up owing to death or withdrawal, 28/65 patients (43.1%) remained colonised at Month 4; 16/42 (38.1%) and 5/28 (17.9%) were found colonised up to Months 8 and 12, respectively. Colonisation persistence was more frequent in patients with bacteraemia or complicated urinary tract infection while in hospital and in those staying in long-term care facilities (LTCFs). Clonal characteristics of CP-KP isolates did not appear to influence persistence. Isolates obtained from each persistent carrier were identical or highly related by SNP phylogenetic analysis. Identification of patients at higher risk of persistent intestinal carriage after hospital discharge can prompt control measures to limit the transmission of CPE in the community, especially in LTCF settings.

摘要

产碳青霉烯酶肠杆菌科(CPE)对全球公共健康构成严重威胁。老年人发生 CPE 定植/感染的风险增加。本研究旨在评估意大利出院老年患者 CPE 定植的持续性和持续定植菌株的基因型特征。在两个意大利城市(2018 年 3 月至 2020 年 9 月)开展了一项纵向研究,纳入 137 名年龄≥65 岁且出院时存在肠道 CPE 定植的患者。在出院后 4、8 和 12 个月评估 CPE 定植情况。采用竞争风险分析探讨基线特征与 4 个月时持续性的关联。对所有分离株进行碳青霉烯酶分型和多位点序列分型。对所有持续性分离株进行全基因组测序。137 例患者中,91%携带产碳青霉烯酶肺炎克雷伯菌(CP-KP),8.8%携带产碳青霉烯酶大肠埃希菌。尽管由于死亡或退出,大量患者失访,但 65 例患者中有 28 例(43.1%)在第 4 个月仍定植;42 例中有 16 例(38.1%)和 28 例中有 5 例(17.9%)分别在第 8 和 12 个月定植。住院期间合并菌血症或复杂尿路感染以及入住长期护理机构(LTCF)的患者,定植持续性更常见。CP-KP 分离株的克隆特征似乎不影响持续性。通过 SNP 系统发育分析,从每个持续性携带者获得的分离株均相同或高度相关。确定出院后肠道持续携带风险较高的患者,可促使采取控制措施限制社区中 CPE 的传播,尤其是在 LTCF 环境中。

相似文献

1
Dynamics of carbapenemase-producing Enterobacterales intestinal colonisation in the elderly population after hospital discharge, Italy, 2018-2020.2018-2020 年意大利老年人群出院后产碳青霉烯酶肠杆菌科肠道定植的动态。
Int J Antimicrob Agents. 2022 Jun;59(6):106594. doi: 10.1016/j.ijantimicag.2022.106594. Epub 2022 Apr 25.
2
Clinical Characteristics of and Risk Factors for Subsequent Carbapenemase-producing Enterobacterales (CPE) Bacteraemia in Rectal CPE Carriers.直肠携带碳青霉烯酶肠杆菌科细菌(CPE)患者中 CPE 血流感染的临床特征和危险因素。
Int J Antimicrob Agents. 2023 Nov;62(5):106959. doi: 10.1016/j.ijantimicag.2023.106959. Epub 2023 Aug 24.
3
Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017.2015 年至 2017 年间,泰国曼谷诗里拉吉医院定植患者的产多药耐药碳青霉烯酶 ST231 和 ST16 肺炎克雷伯菌的基因组和临床特征。
BMC Infect Dis. 2021 Feb 4;21(1):142. doi: 10.1186/s12879-021-05790-9.
4
Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.某大学医院 ICU 和 HSCT 病房高危患者中产碳青霉烯酶肠杆菌科直肠定植的流行病学和危险因素。
Antimicrob Resist Infect Control. 2020 Sep 23;9(1):155. doi: 10.1186/s13756-020-00816-4.
5
Longitudinal Genomic Characterization of Carbapenemase-producing Enterobacteriaceae (CPE) Reveals Changing Pattern of CPE Isolated in Hong Kong Hospitals.产碳青霉烯酶肠杆菌科(CPE)的纵向基因组特征分析揭示了香港医院分离的 CPE 模式的变化。
Int J Antimicrob Agents. 2021 Nov;58(5):106430. doi: 10.1016/j.ijantimicag.2021.106430. Epub 2021 Sep 12.
6
Clonal spread of carbapenemase-producing Enterobacteriaceae in a region, China.中国某地区产碳青霉烯酶肠杆菌科细菌的克隆传播。
BMC Microbiol. 2022 Mar 29;22(1):81. doi: 10.1186/s12866-022-02497-y.
7
Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.采用小鼠大腿感染模型,对美罗培南、头孢吡肟或氨曲南与新型β-内酰胺酶抑制剂那库巴坦联合用药,针对耐碳青霉烯类和/或产碳青霉烯酶的肺炎克雷伯菌和大肠埃希菌进行药效学评价。
Int J Antimicrob Agents. 2021 May;57(5):106330. doi: 10.1016/j.ijantimicag.2021.106330. Epub 2021 Mar 28.
8
Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year.在一家长期护理机构中,产超广谱β-内酰胺酶和产碳青霉烯酶肠杆菌科细菌、耐万古霉素肠球菌以及耐甲氧西林金黄色葡萄球菌的定植情况持续了一年。
BMC Infect Dis. 2015 Apr 1;15:168. doi: 10.1186/s12879-015-0880-5.
9
Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance.荷兰产碳青霉烯酶肠杆菌科细菌的分子特征;2014-2018 年全国实验室监测结果。
Clin Microbiol Infect. 2020 Oct;26(10):1412.e7-1412.e12. doi: 10.1016/j.cmi.2020.01.027. Epub 2020 Feb 5.
10
Nationwide, population-based observational study of the molecular epidemiology and temporal trend of carbapenemase-producing Enterobacterales in Norway, 2015 to 2021.2015 年至 2021 年,挪威全国范围内基于人群的产碳青霉烯酶肠杆菌科分子流行病学和时间趋势的观察性研究。
Euro Surveill. 2023 Jul;28(27). doi: 10.2807/1560-7917.ES.2023.28.27.2200774.

引用本文的文献

1
Panel data analysis of spatial effects carbapenem-resistant organisms in mainland China.中国大陆耐碳青霉烯类微生物空间效应的面板数据分析
Sci Rep. 2025 Jul 15;15(1):25457. doi: 10.1038/s41598-025-09712-6.
2
One-year monitorization of the gut colonization by multidrug resistant bacteria in elderly of a single long-term care facility.对单一长期护理机构中老年人肠道多重耐药菌定植情况进行的为期一年的监测。
JAC Antimicrob Resist. 2025 Feb 8;7(1):dlaf008. doi: 10.1093/jacamr/dlaf008. eCollection 2025 Feb.
3
Prognostic nomograms for locally advanced cervical cancer based on the SEER database: Integrating Cox regression and competing risk analysis.
基于 SEER 数据库的局部晚期宫颈癌预后列线图:Cox 回归和竞争风险分析的整合。
Medicine (Baltimore). 2024 Nov 8;103(45):e40408. doi: 10.1097/MD.0000000000040408.
4
Healthcare as a driver, reservoir and amplifier of antimicrobial resistance: opportunities for interventions.医疗保健是抗菌药物耐药性的驱动因素、储存库和放大器:干预的机会。
Nat Rev Microbiol. 2024 Oct;22(10):636-649. doi: 10.1038/s41579-024-01076-4. Epub 2024 Jul 24.
5
Detection of KPC-216, a Novel KPC-3 Variant, in a Clinical Isolate of ST101 Co-Resistant to Ceftazidime-Avibactam and Cefiderocol.在一株对头孢他啶-阿维巴坦和头孢地尔耐药的ST101临床分离株中检测到新型KPC-3变体KPC-216。
Antibiotics (Basel). 2024 May 29;13(6):507. doi: 10.3390/antibiotics13060507.
6
Prevalence of intestinal colonization and nosocomial infection with carbapenem-resistant in children: a retrospective study.儿童耐碳青霉烯肠杆菌定植和医院感染的流行情况:一项回顾性研究。
Front Public Health. 2023 Nov 23;11:1251609. doi: 10.3389/fpubh.2023.1251609. eCollection 2023.
7
Whole-Genome Sequencing and Molecular Analysis of Ceftazidime-Avibactam-Resistant KPC-Producing from Intestinal Colonization in Elderly Patients.老年患者肠道定植产KPC的头孢他啶-阿维巴坦耐药菌的全基因组测序及分子分析
Antibiotics (Basel). 2023 Aug 3;12(8):1282. doi: 10.3390/antibiotics12081282.
8
Ceftazidime-avibactam resistance in sequence type 37: a decade of persistence and concealed evolution.序列类型 37 中的头孢他啶-阿维巴坦耐药性:十年的持续存在和隐蔽进化。
Microb Genom. 2023 Feb;9(2). doi: 10.1099/mgen.0.000931.
9
Whole Genome Sequencing and Molecular Analysis of Carbapenemase-Producing from Intestinal Carriage in Elderly Inpatients.老年住院患者肠道携带产碳青霉烯酶菌的全基因组测序及分子分析
Microorganisms. 2022 Aug 3;10(8):1561. doi: 10.3390/microorganisms10081561.